Treatments

To date, there is no cure for Alzheimer’s disease. However, treatments that may alter the course of the disease are currently being researched and offer hope.

We currently have symptomatic treatments that primarily target cognitive symptoms and behavioural disorders. These drugs are symptomatic in the sense that they do not affect the aetiopathogenic mechanisms of the disease (they are not curative).

Four drugs are currently available and reimbursed by social security funds: ARICEPT (donepezil), REMINYL (galantamine), EXELON (rivastigmine) and EBIXA (memantine).

These drugs are designed to slow the progression and worsening of symptoms and to control behavioural disorders. They are mainly used to treat symptoms in the mild to moderate stages of the disease.

In addition to these drugs, the doctor may prescribe certain molecules such as antidepressants, anxiolytics, sleeping pills or sometimes antipsychotics (when behavioural disorders are significant).

Numerous non-drug therapies are also offered to patients and form an integral part of their treatment. These aim to maintain the patient’s remaining abilities for as long as possible. Various types of interventions are available, such as speech therapy, psychological therapy, neuropsychological therapy, occupational therapy, etc.

Workshops focusing on cognitive, psychological, artistic, physical and other aspects may also be offered.

Depending on the severity of the disease, care in the form of a day centre may also be considered.

At all stages of the disease, the loss of independence and quality of life for the patient and their family are central concerns in treatment.

Care must be comprehensive and take into account all aspects of the disease: neurological, psychological and behavioural.